Business Description
Acasti Pharma Inc
NAICS : 325412
SIC : 3741
ISIN : CA00430K4028
Share Class Description:
TSXV:ACST: Class ACompare
Compare
Traded in other countries / regions
ACST.USAA1P0.GermanyACST.Canada IPO Date
2011-03-31Description
Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all of which could help to increase treatment compliance and improve patient outcomes.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1046.42 | |||||
| Equity-to-Asset | 0.85 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 42.8 | |||||
| 3-Year EPS without NRI Growth Rate | 47.7 | |||||
| 3-Year FCF Growth Rate | 45.5 | |||||
| 3-Year Book Growth Rate | 9.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -2.44 | |||||
| 12-1 Month Momentum % | -48.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 15.19 | |||||
| Quick Ratio | 15.19 | |||||
| Cash Ratio | 14.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -58.2 | |||||
| Shareholder Yield % | -25.54 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -53.84 | |||||
| ROA % | -45.79 | |||||
| ROIC % | -17.36 | |||||
| ROC (Joel Greenblatt) % | -4341.47 | |||||
| ROCE % | -14.91 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.42 | |||||
| Price-to-Tangible-Book | 1.78 | |||||
| EV-to-EBIT | -0.18 | |||||
| EV-to-EBITDA | -0.18 | |||||
| EV-to-FCF | -0.16 | |||||
| Price-to-Net-Current-Asset-Value | 1.78 | |||||
| Price-to-Net-Cash | 1.97 | |||||
| Earnings Yield (Greenblatt) % | -555.56 | |||||
| FCF Yield % | -49.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Acasti Pharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | 0 | ||
| Beta | 0 | ||
| Volatility % | 65.25 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (C$) | 0.036429 | ||
| 20-Day SMA (C$) | 0 | ||
| 12-1 Month Momentum % | -48.72 | ||
| 52-Week Range (C$) | 0.47 - 1.66 | ||
| Shares Outstanding (Mil) | 44.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Acasti Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Acasti Pharma Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Acasti Pharma Inc Frequently Asked Questions
What is Acasti Pharma Inc(TSXV:ACST)'s stock price today?
The current price of TSXV:ACST is C$0.57. The 52 week high of TSXV:ACST is C$1.66 and 52 week low is C$0.47.
When is next earnings date of Acasti Pharma Inc(TSXV:ACST)?
The next earnings date of Acasti Pharma Inc(TSXV:ACST) is 2024-06-21 Est..
Does Acasti Pharma Inc(TSXV:ACST) pay dividends? If so, how much?
Acasti Pharma Inc(TSXV:ACST) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers